Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Nef Stories

2013-05-02 23:17:46

By investing in the integration of technology into the classroom setting, NEF´s CyberLearning platform provides an innovative method for the integration of STEM + (Science, Technology, Engineering and Math, English, Social Studies, SAT/ACT, IT and Business) education in the classroom. NEF is now accepting applications for its 50% match with a June 1 deadline. (PRWEB) May 02, 2013 NEF´s CyberLearning STEM+ academies, administered by the State University of NY (SUNY) and local...

2013-03-13 23:02:49

Ohio´s Third Grade reading guarantee finds champion in NEF's CyberLearning program. NEF´s STEM+ academies can improve a child's reading by one grade level in 25 hours. Alexandria, VA (PRWEB) March 13, 2013 Ohio´s department of education is implementing a Third Grade reading guarantee. This initiative is an incentive for teachers to have students reading proficiently by the third grade. NEF´s STEM+ academies an aid in this effort as its CyberLearning program can improve...

2012-11-13 12:25:12

NEW YORK, Nov. 13, 2012 /PRNewswire/ -- Celebrity Masks by: Michael Bastian, Chris Benz, Charlotte Ronson, Patricia Underwood, Rolando Santana, Wendy Williams, and host Mondo Guerra www.ascnyc.org/unmask Facebook.com/ascnyc WHAT: Unmask AIDS, the annual fall gala benefiting ASCNYC WHEN: Thursday, November 29, 6:00-10:00pm. Red-carpet and celebrity photo ops! WHERE: Bryant Park Grill 25 West 40th Street New York City WHY:...

2012-09-12 00:57:17

Novel method could help advance the fight against persistent 'HIV latency' Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection–by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS. In a paper being published online today in Lab on a Chip, the laboratory of Gladstone Investigator Leor Weinberger, PhD, announced...

2012-05-31 11:52:07

After being infected with SIV, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, and for 6 months after infection were better able to control the virus After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, and for six months after...

2012-03-27 01:01:41

The hallmark loss of helper CD4+ T cells during human immunodeficiency virus (HIV) infection may be a red herring for therapeutics, according to a study published on March 26th in the Journal of Experimental Medicine. HIV preferentially infects CD4+ T cells, immune cells required to generate protective antibodies. In many people, this leads to a progressive drop in CD4+ T cell numbers–and the more the numbers fall, the faster AIDS develops. HIV-induced cell loss includes both 'naive'...

2012-03-21 10:24:37

Using data from the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE), Jim Young and colleagues from The Opportunistic Infections Project Team of COHERE show in this week's PLoS Medicine that in successfully treated patients, the risk of a new AIDS event or death follows a CD4 cell count gradient in patients with viral suppression. An increase in CD4 cell count provides the greatest benefit for patients with a CD4 cell count below 200 cells/µL but still...

2012-01-05 04:46:00

LEIDEN, Netherlands, January 5, 2012 /PRNewswire/ -- Preclinical Study Provides Strong Rationale for HIV Vaccine Clinical Trials Results from a recent study present new insights into the immune responses underlying protection against HIV infection and provide a path forward for HIV vaccine development. Published in this week's online version of the journal Nature, the study shows that novel vaccine combinations can provide partial protection against infection by Simian...

2011-12-23 01:02:59

A clinical trial that revitalized HIV research tops the journal's list of advances in 2011 The journal Science has lauded an eye-opening HIV study, known as HPTN 052, as the most important scientific breakthrough of 2011. This clinical trial demonstrated that people infected with HIV are 96 percent less likely to transmit the virus to their partners if they take antiretroviral drugs (ARVs). The findings end a long-standing debate over whether ARVs could provide a double benefit by...